Contribution of APCs to mucosal-associated invariant T cell activation in infectious disease and cancer
journal contributionposted on 2021-08-17, 10:38 authored by Muki Shehu Shey, Avuyonke Balfour, Katalin Andrea Wilkinson, Graeme Meintjes
APCs such as monocytes and dendritic cells are among the first cells to recognize invading pathogens and initiate an immune response. The innate response can either eliminate the pathogen directly, or through presentation of Ags to T cells, which can help to clear the infection. Mucosal-associated invariant T (MAIT) cells are among the unconventional T cells whose activation does not involve the classical co-stimulation during Ag presentation. MAIT cells can be activated either via presentation of unconventional Ags (such as riboflavin metabolites) through the evolutionarily conserved major histocompatibility class I-like molecule, MR1, or directly by cytokines such as IL-12 and IL-18. Given that APCs produce cytokines and can express MR1, these cells can play an important role in both pathways of MAIT cell activation. In this review, we summarize evidence on the role of APCs in MAIT cell activation in infectious disease and cancer. A better understanding of the interactions between APCs and MAIT cells is important in further elucidating the role of MAIT cells in infectious diseases, which may facilitate the design of novel interventions such as vaccines.
Antigen presenting cellsIL-12IL-18MAIT cell activationMR1cancerinfectious diseaseAntigen PresentationAntigen-Presenting CellsCommunicable DiseasesHistocompatibility Antigens Class IHumansInterleukin-12Interleukin-18Lymphocyte ActivationMucosal-Associated Invariant T CellsNeoplasmsReceptors, Antigen, T-Cell, alpha-betaWilkinson, R FC001218Immunology0601 Biochemistry and Cell Biology0605 Microbiology1107 Immunology